Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Jun 22, 2022

Accession no.
0001209191-22-038619
Filed
Jun 22, 2022, 6:59 AM ET
Trade date
Jun 21, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market purchases total $478.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 21, 2022Common StockPPurchaseAcquired+29,715$2.39+$70,870.28196,436,409Indirect
Jun 21, 2022Common StockPPurchaseAcquired+4,000$2.39+$9,556196,440,409Indirect
Jun 21, 2022Common StockPPurchaseAcquired+49,778$2.39+$118,969.42196,490,187Indirect
Jun 21, 2022Common StockPPurchaseAcquired+40,009$2.40+$95,821.56196,530,196Indirect
Jun 21, 2022Common StockPPurchaseAcquired+68,340$2.40+$164,016196,598,536Indirect
Jun 21, 2022Common StockPPurchaseAcquired+7,466$2.41+$17,955.73196,606,002Indirect
Jun 21, 2022Common StockPPurchaseAcquired+692$2.41+$1,667.72196,606,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)